Tuesday, september 21, 2021 tagFinancial results

Date of approval of the final consolidated financial statements for the year ending June 2021

  • SHARE ON
  • twitter
  • facebook
  • linkedin

It is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021.

Ramsay Santé
In its press release of August 25, 2021 relating to the publication of the provisional annual results at the end of June 2021, Ramsay Santé indicated that the final consolidated financial statements for the year ended June 2021 would be approved by the Board of Directors at its meeting on September 23, 2021.

As the finalization of these financial statements and their review by the auditors will require additional time, it is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021.

ISIN code and Euronext Paris: FR0000044471
Website: www.ramsaygsante.eu


Investor Relations/Analysts
Marcus Nord
Tél. +46 733 97 72 57
marcus.nord@capio.com

Press Relations
Brigitte Cachon
Tél. +33 6 12 29 56 52
b.cachon@ramsaygds.fr

About Ramsay Santé

After the acquisition of the Capio Group in 2018, Ramsay Santé has become the leading European provider of comprehensive healthcare services. The group now has 36,000 employees and works with nearly 8,600 private practitioners.

Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 establishments.

In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres.

The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS).

The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.

Tuesday, september 21, 2021 tagFinancial results
  • SHARE ON
  • twitter
  • facebook
  • linkedin
Downloads
Contact
  • Brigitte Cachon
  • Director of Communication, Brand & CSR
  • +33 (0)1 87 86 22 11
Related News
View all releases